BDBM285966 US10081617, Example 113::US10081617, Example 114::methyl (4-{2-[4-chloro-3-(5- chloro-2-cyanophenyl)-7- hydroxy-1-oxido-6,7-dihydro- 5H-cyclopenta[b]pyridin-7-yl]- 1H-imidazol-4- yl}phenyl)carbamate

SMILES COC(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C1(O)CCc2c1[n+]([O-])cc(c2Cl)-c1cc(Cl)ccc1C#N

InChI Key InChIKey=NFSJMDKULQTJQH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 285966   

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285966(US10081617, Example 114 | methyl (4-{2-[4-chloro-3...)
Affinity DataIC50: 6.05nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285966(US10081617, Example 114 | methyl (4-{2-[4-chloro-3...)
Affinity DataIC50: 813nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent